This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2006 Dec;11(6):170.

doi: 10.1136/ebm.11.6.170.

Clopidogrel plus aspirin was inferior to oral anticoagulation for preventing vascular events in atrial fibrillation

Michael A Sloan¹

Affiliations

PMID: 17213164
DOI: 10.1136/ebm.11.6.170

Comment

Clopidogrel plus aspirin was inferior to oral anticoagulation for preventing vascular events in atrial fibrillation

Michael A Sloan. Evid Based Med. 2006 Dec.

. 2006 Dec;11(6):170.

doi: 10.1136/ebm.11.6.170.

Author

Michael A Sloan¹

Affiliation

¹ Carolinas Medical Center, Charlotte, North Carolina, USA.

PMID: 17213164
DOI: 10.1136/ebm.11.6.170

No abstract available

PubMed Disclaimer

Comment on

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.
ACTIVE Writing Group of the ACTIVE Investigators; Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, Chrolavicius S, Pfeffer M, Hohnloser S, Yusuf S. ACTIVE Writing Group of the ACTIVE Investigators, et al. Lancet. 2006 Jun 10;367(9526):1903-12. doi: 10.1016/S0140-6736(06)68845-4. Lancet. 2006. PMID: 16765759 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.